Real-time molecular vision
Truth in Every Layer: Real-Time AI for Surgery & Diagnostics
revolutionize surgical precision and diagnostic speed
REVEAL LIFE SCIENCE is a life-science technology platform that develops AI, molecular data infrastructure, and analytics to support regulated clinical products and future diagnostics.
We operate as a centralized R&D engine that pioneers breakthrough Raman spectroscopy technology, then transitions mature products into dedicated operating companies for focused commercialization.
With over a decade of research, clinical collaborations, and AI innovation, Reveal Life Science is transforming how medicine sees the unseen—bringing molecular precision to surgeons in the operating room and instant diagnostic insights to patients worldwide. Clinical products are developed and commercialized by affiliates, including Reveal Surgical.
All divisions
-
![Reveal Surgical logo]()
An investigational medical device company developing Sentry™ as an intraoperative decision-support tool for cancer surgery.
-
![Reveal Biofluid]()
Bringing lab-grade diagnostics to saliva, urine, and blood testing. Reveal Biofluids is a research program exploring biofluid spectroscopy for future diagnostic applications.
-
![Reveal Insight AI logo]()
Reveal Insight Atlas integrates molecular analytics, AI, and cloud architecture to deliver continuous, real-time intelligence from millions of spectral data points — Atlas is A research dataset developed through ethically approved clinical studies to improve future model development. Atlas is not a clinical product and is not used for real-time medical decision-making.
Clinical evidence
-
500+ patients
-
21 studies
-
90%+ accuracy
-
FDA Breakthrough
Reveal platform
Our integrated platform delivers unprecedented precision across surgical and diagnostic applications, powered by years of proprietary AI development.
Through Raman spectroscopy combined with real‑time AI, Reveal provides surgeons and clinicians with molecular‑level insights that were previously invisible. This means fewer reoperations, faster diagnostics, and better outcomes for patients.
Beyond surgery, our platform extends to biofluids and non‑invasive testing, enabling rapid detection of disease markers in saliva, urine, and blood. With secure cloud integration and a continuously expanding molecular atlas, Reveal bridges the gap between research, clinics, and everyday healthcare.
Reveal surgical
Sentry™ Surgical Platform
Intraoperative decision-support technologies for tissue characterization
Sentry™ Precision
Investigational intraoperative tissue characterization system for neurosurgery
Intended to provide real-time molecular information to support surgical decision-making during brain tumor resection
PMA regulatory pathway
Sentry™ Scanner
Investigational ex vivo tissue assessment system for breast surgery
Intended to support intraoperative evaluation of excised tissue margins during lumpectomy procedures
NaviSense™
Investigational endoscopic tissue guidance system
Intended to support tissue targeting during minimally invasive endoscopic procedures
510(k) regulatory pathway anticipated
Reveal BIOFLUIDS
Reveal Biofluids: Rapid Diagnostic Revolution
Reveal Biofluids is transforming diagnostics by enabling real‑time detection of disease markers in saliva, urine, and blood — without the need for invasive procedures or lengthy lab analysis. Our platform brings laboratory‑grade accuracy directly to the point of care.
From early cancer detection to metabolic monitoring and infectious disease screening, our biofluid technology delivers fast, affordable, and scalable solutions. By combining spectroscopy with machine learning (ML), we empower clinicians, pharmacies, and even remote healthcare providers to make faster, data-driven decisions that save lives.
Reveal INSIGHt ATLAS
Reveal InsighT — The Unified Platform for Molecular Intelligence
Reveal Insight Atlas operate as a single molecular intelligence ecosystem — combining the world’s first spectral data warehouse with a secure, cloud-based AI engine.
By organizing and analyzing millions of spectral signatures from tissues and biofluids, the platform transforms raw molecular data into clear, real-time insights.
This continuous learning system empowers clinicians, researchers, and health networks with precision diagnostics, treatment decision support, and population-scale analytics — bridging the gap between molecular discovery and clinical action.
Unleashing the Power of Real‑Time Molecular Insights
-
Faster Than Ever
Detect critical changes in real time, from cancer cells to environmental anomalies, with results in seconds.
-
A Unique Data Source
Reveal A.I builds an unprecedented molecular database − rich in biomarkers, spectra, and physico‑chemical patterns − that drives smarter therapeutic decisions and innovations.
-
Cost‑Effective Precision
Diagnostics that aim to improve speed and accessibility, supporting broader access to high-impact testing.
-
Non‑Invasive & Multi‑Purpose
Analyze biofluids, environmental samples, and industrial liquids without invasive procedures or sample preparation.
-
Proactive Health Monitoring
Potential to support faster clinical monitoring across a range of health conditions.
-
Remote-Ready Technology
Deployable in remote or extreme environments, ensuring vital data collection and diagnostics anywhere.
-
AI-Powered Evolution
Our proprietary SaaS platform continuously integrates new capabilities and biomarkers via simple software updates, adapting to emerging needs.
-
Validated by Global Experts
Backed by over 9 years of research and 180+ peer-reviewed publications, trusted by hospitals, universities, and government institutions across three continents.
-
Multi-Domain Impact
From precision surgery to pandemic prevention, Reveal Explorer and Reveal SENTRY™ support smarter decisions in healthcare, animal health, food safety, and industrial monitoring.
